ArticleHepatology (Baltimore, Md.)2026

The development of a pan-genotypic T cell vaccine against hepatitis C virus using heterologous prime-boost strategies.

Rebecca Strain et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.